Join leading experts for a focused discussion on how New Approach Methodologies (NAMs), including organoids, micro‑physiological systems, organs‑on‑a‑chip, and advanced AI‑driven models are transforming precision medicine. With nearly 90% of drugs that succeed in animal models failing in human trials, NAMs offer a more accurate path to predicting treatment response, improving outcomes, and lowering overall health care costs.
What We'll Cover
- How NAMs improve the predictive power of preclinical models.
- Why patient-specific date and diverse representation matter.
- Opportunities and challenges in bringing NAMs into clinical practice.
Location